Literature DB >> 22461318

SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations.

Adriana Goncalves1, Evren Karayel, Gillian I Rice, Keiryn L Bennett, Yanick J Crow, Giulio Superti-Furga, Tilmann Bürckstümmer.   

Abstract

Aicardi-Goutières syndrome (AGS) is a rare inherited autoimmune disease caused by mutations in genes encoding the RNase H2 subunits A, B, and C; the DNase three prime repair exonuclease 1 (TREX1); and sterile alpha motif (SAM) domain and HD domain-containing protein 1 (SAMHD1). Using unbiased affinity purification coupled to protein mass spectrometry, we identify SAMHD1 as a nucleic-acid-binding protein displaying a preference for RNA over DNA. In contrast to TREX1 and the RNase H2 complex, SAMHD1 has no obvious nuclease activity. In addition, interrogating truncation mutants of SAMHD1 observed in AGS patients, we map the nucleic-acid-binding domain to residues 164-442, thus overlapping with the HD domain. Furthermore, we show that although wild-type SAMHD1 displays almost exclusive nuclear localization, 11 of 12 SAMHD1 mutants show at least partial mislocalization to the cytosol. Overall, these data suggest that SAMHD1 has a role in the nucleus that, if disrupted by mutation, leads to cytosolic accumulation of SAMHD1 and autoimmune disease.
© 2012 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22461318     DOI: 10.1002/humu.22087

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  77 in total

Review 1.  HIV suppression by host restriction factors and viral immune evasion.

Authors:  Xiaofei Jia; Qi Zhao; Yong Xiong
Journal:  Curr Opin Struct Biol       Date:  2015-05-16       Impact factor: 6.809

2.  SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4+ T Cells.

Authors:  Jenna M Antonucci; Sun Hee Kim; Corine St Gelais; Serena Bonifati; Tai-Wei Li; Olga Buzovetsky; Kirsten M Knecht; Alice A Duchon; Yong Xiong; Karin Musier-Forsyth; Li Wu
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

3.  Functional analysis of the relationship between Vpx and the restriction factor SAMHD1.

Authors:  Gregory Berger; Jocelyn Turpin; Stéphanie Cordeil; Kevin Tartour; Xuan-Nhi Nguyen; Renaud Mahieux; Andrea Cimarelli
Journal:  J Biol Chem       Date:  2012-10-17       Impact factor: 5.157

4.  Impaired dNTPase activity of SAMHD1 by phosphomimetic mutation of Thr-592.

Authors:  Chenxiang Tang; Xiaoyun Ji; Li Wu; Yong Xiong
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

5.  SAMHD1 deficient human monocytes autonomously trigger type I interferon.

Authors:  Alicia Martinez-Lopez; Marta Martin-Fernandez; Sofija Buta; Baek Kim; Dusan Bogunovic; Felipe Diaz-Griffero
Journal:  Mol Immunol       Date:  2018-08-09       Impact factor: 4.407

Review 6.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

7.  Low dNTP levels are necessary but may not be sufficient for lentiviral restriction by SAMHD1.

Authors:  Sarah Welbourn; Klaus Strebel
Journal:  Virology       Date:  2015-12-04       Impact factor: 3.616

Review 8.  Mouse models for Aicardi-Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunity.

Authors:  R Behrendt; A Roers
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

9.  Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1.

Authors:  Tommy E White; Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Sarah Amie; Laura Nguyen; Baek Kim; Jurgen Brojatsch; Felipe Diaz-Griffero
Journal:  Virology       Date:  2012-11-13       Impact factor: 3.616

10.  HIV-2 and SIVmac accessory virulence factor Vpx down-regulates SAMHD1 enzyme catalysis prior to proteasome-dependent degradation.

Authors:  Maria DeLucia; Jennifer Mehrens; Ying Wu; Jinwoo Ahn
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.